Illumina (ILMN) will release TruSight Oncology 500 v2, a new version of its flagship cancer research assay to enable comprehensive genomic ...
TruSight Oncology portfolio enables clinical research and in-vitro diagnostic CGP solutions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback